D. E. Shaw & Co., Inc. Dexcom Inc Put Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Put Options

20 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $408,147 - $519,664	-3,700 Reduced 9.05%	37,200 $4.22 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $4.87 Million - $5.97 Million	-42,600 Reduced 51.02%	40,900 $5.67 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $5.66 Million - $9.31 Million	75,000 Added 882.35%	83,500 $10.4 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $516,360 - $827,580	6,000 Added 240.0%	8,500 $793,000
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $17.8 Million - $21 Million	-171,200 Reduced 98.56%	2,500 $290,000
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $12.4 Million - $17.9 Million	-146,000 Reduced 45.67%	173,700 $19.7 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $4.42 Million - $5.45 Million	-57,900 Reduced 15.33%	319,700 $25.7 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $20.9 Million - $40.8 Million	307,300 Added 437.13%	377,600 $28.1 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $5.38 Million - $7.45 Million	-57,200 Reduced 44.86%	70,300 $36 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $2.81 Million - $3.52 Million	-21,600 Reduced 14.49%	127,500 $68.5 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $1.08 Million - $1.45 Million	10,100 Added 7.27%	149,100 $81.5 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $3.42 Million - $4.55 Million	42,200 Added 43.6%	139,000 $59.4 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $949,648 - $1.17 Million	-11,200 Reduced 10.37%	96,800 $34.8 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $663,000 - $888,250	-8,500 Reduced 7.3%	108,000 $39.9 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $5.02 Million - $5.94 Million	52,600 Added 82.32%	116,500 $48 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $1.13 Million - $1.9 Million	18,000 Added 39.22%	63,900 $25.9 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $1.95 Million - $3.09 Million	40,900 Added 818.0%	45,900 $12.4 Million
Q4 2018 Feb 14, 2019	BUY	$26.99 - $37.37 $134,950 - $186,850	5,000 New	5,000 $599,000
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $111,199 - $153,800	-10,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $113,600 - $189,800	10,000	10,000 $489,000

Others Institutions Holding DXCM

# of Institutions

1,016

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account